Compare NSPR & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSPR | MGLD |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 44.8M |
| IPO Year | 2009 | 2021 |
| Metric | NSPR | MGLD |
|---|---|---|
| Price | $0.46 | $1.98 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | 108.5K | ★ 395.8K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.57 |
| EPS | N/A | ★ N/A |
| Revenue | $2,310,000.00 | ★ $34,876,734.00 |
| Revenue This Year | $9.14 | N/A |
| Revenue Next Year | $105.44 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.46 | $0.84 |
| 52 Week High | $2.41 | $2.12 |
| Indicator | NSPR | MGLD |
|---|---|---|
| Relative Strength Index (RSI) | 24.56 | 77.91 |
| Support Level | N/A | $0.91 |
| Resistance Level | $1.00 | $2.12 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.19 | 31.25 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.